EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Event preview of the RNA Leaders APAC Congress

No authors Listed

Nucleic Acid Insights · 06.08.2026 · 3 (6)

DOI: 10.18609/nai.2026.057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 06.08.2026. Verfasst von No authors Listed. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As RNA therapeutics extend beyond established vaccine and gene-silencing applications toward wider clinical and commercial adoption across Asia-Pacific, Nucleic Acid Insights turns its attention to RNA Leaders APAC 2026, the Asia-Pacific edition of the RNA Leaders series, taking place in Singapore, September 1–2, 2026. Co-located with the AsiaBio Partnering Forum, the meeting convenes leading scientists, biotech executives, investors, and industry experts. Tailored to the region's distinct challenges and opportunities, the program spans progress in mRNA technology, RNA-based drug delivery systems, oligonucleotide therapeutics, regulatory challenges across Asia-Pacific and Western jurisdictions, and commercialization strategies, with particular attention to developments emerging from the Asia-Pacific region. This preview highlights the key sessions, speakers, and themes shaping the RNA field agenda across Asia-Pacific.

Zitieren

APA

Listed, N. A. (2026). Event preview of the RNA Leaders APAC Congress. Nucleic Acid Insights, 3(6). https://doi.org/10.18609/nai.2026.057

Vancouver

Listed NA. Event preview of the RNA Leaders APAC Congress. Nucleic Acid Insights. 2026;3(6). doi:10.18609/nai.2026.057

BibTeX
@article{Listed2026,
  author = {Listed, No authors},
  title = {Event preview of the RNA Leaders APAC Congress},
  journal = {Nucleic Acid Insights},
  year = {2026},
  volume = {3},
  number = {6},
  doi = {10.18609/nai.2026.057}
}
Kostenlos starten →